Retinitis Pigmentosa (RP) is a group of inherited retinal disorders that cause progressive degeneration of rod and cone photoreceptor cells, typically beginning with night blindness and peripheral vision loss before affecting central vision. There is currently no treatment that reverses RP or corrects its underlying genetic causes in most cases. For patients who have exhausted standard options, some explore stem cell therapy as an additional avenue to discuss with a specialist, alongside genetic counselling and low-vision support.
RP has no broadly approved treatment that halts or reverses progression for most genetic subtypes, and care typically focuses on monitoring, genetic counselling, and low-vision rehabilitation. Patients who want to understand whether regenerative approaches may be relevant to their case sometimes seek a specialist evaluation that combines advanced retinal imaging with an opinion on stem cell therapy.
Dr. Tyagi leads the regenerative medicine protocol design at Stem Cell Cure India, overseeing stem cell sourcing, lab processing, and treatment planning for every patient's individual case.
Dr. Pallavee brings over two decades of clinical ophthalmology experience, supporting the eye-specific evaluation and treatment planning for patients undergoing stem cell therapy for retinitis pigmentosa and other retinal conditions at Stem Cell Cure India.
Consultant Ophthalmologist & Eye Surgeon
Specialist in advanced cataract surgery, refractive surgery, and Corneal Cross-Linking for Keratoconus with extensive clinical experience.
Associate Professor | Vitreo-Retina Surgeon
Experienced cataract and vitreo-retina surgeon with expertise in retinal disorders, diabetic retinopathy, and advanced retina procedures.
Mesenchymal Stem Cells (MSCs) are being studied for their potential neuroprotective and anti-inflammatory effects, and for their possible role in supporting the survival of remaining photoreceptor cells in some RP cases. Stem cell therapy does not correct the underlying genetic mutation in inherited RP, and is not established as a treatment that restores vision already lost. This approach is explored as a complement to — not a replacement for — genetic counselling, low-vision rehabilitation, and monitoring by a retina specialist.
Suitability depends on the specific genetic subtype, stage of disease, and remaining visual function. Before travelling, our team reviews:
No. RP is generally a genetic condition, and stem cell therapy does not correct the underlying mutation. It is explored as an option that may help support remaining retinal function, alongside genetic counselling and low-vision care — it is not a cure.
This varies by genetic subtype and stage of disease. Please share your ERG results, visual field test, and genetic report if available so our team can give an initial opinion.
ERG results, visual field test, recent OCT scan, and genetic test report if you have had one.
Most patients stay between 7 and 10 days, depending on the diagnostic work-up and treatment plan required.
Yes. Once an evaluation is confirmed, we provide the invitation and supporting documents needed to apply for a Medical Visa.
Cost depends on the specific condition, its severity, and the plan required. Contact us for a personalised quote after sharing your reports and medical history.
Source: These are real, verified Google reviews currently published on stemcellcure.in — pulled from our Google Business Profile (5.0★, 33+ reviews).
Contact Stem Cell Cure India today to share your medical history and get a personalised opinion on suitability.
